Advertisement
Organisation › Details
Redmile Group LLC
Redmile Group, LLC is an investment firm with offices in San Francisco and New York that manages approximately $3 billion in global public and private healthcare investments. *
Start | 2007-01-01 established | |
Industry | private equity | |
Industry 2 | LIFE SCIENCES | |
Street | One Letterman Drive Building D, Suite D3-700, The Presidio of San Francisco | |
City | 94129 San Francisco, CA | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 3,000,000,000 (investments managed (2021) 2021-06-23) | |
* Document for »About Section«: Strand Therapeutics Inc.. (6/23/21). "Press Release: Strand Therapeutics Raises $52m in Oversubscribed Series A Round". Cambridge, MA. | ||
Record changed: 2024-02-10 |
Advertisement
More documents for Redmile Group LLC
- [1] Agomab Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent....
- [2] Achilles Therapeutics Ltd.. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top